The OBstetric Lidocaine Patch (OBLido) Trial

Phase 4 Completed 66 enrolled University of Wisconsin, Madison

RandomizedParallel-groupSingle-blindTreatment

Summary

This study will be a single-center, single blind, randomized controlled trial. The study will be conducted at UnityPoint-Health Meriter Hospital under investigators from the University of Wisconsin-Madison. Obstetric patients with prepregnancy obesity undergoing a Cesarean delivery at UnityPoint-Health Meriter will be eligible.

Timeline

Start: 2019-02-15
Primary completion: 2019-09-09
Completion: 2019-11-30

Publications

Antony KM, Adams JH, Jacques L, Hetzel S, Chappell RJ, Gnadt SE, Tevaarwerk AJ. Lidocaine patches for postcesarean pain control in obese women: a pilot randomized controlled trial. Am J Obstet Gynecol MFM. 2021 Jan;3(1):100281. doi: 10.1016/j.ajogmf.2020.100281. Epub 2020 Nov 26.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Lidocaine	Other / unclassified	5 %	Other

Indications

No indication recorded.